AT A GLANCE:
ABOUT SCCA PROTON THERAPY, A PROCURE CENTER Seattle, Wash.

Timeline

• SCCA and ProCure announce plans to develop center on Sept. 28, 2009
• Groundbreaking ceremony on March 22, 2011
• Center estimated to open 2013

Financing

• All private financing secured
• Development of the Center made possible by federal support and private grants, including support from the Norcliffe Foundation

Equipment

• FDA-approved proton therapy equipment manufactured by IBA, Louvain-la-Neuve, Belgium

Design

• Design completed by Tsoi Kobus & Associates, Cambridge, Mass.
• 60,000 sq. ft.
• Two inclined-beam rooms
• One fixed beam room
• One gantry treatment room

Construction

• Estimated completion in 2013

Development Team

• ProCure Treatment Centers, Inc., a team of nationally renowned experts in developing proton centers, provides management support and a model for the complete design, construction, financing, staffing, training and day-to-day operations of world-class proton therapy centers across the United States.

Radiation Oncology Group

• Radiation oncologists from SCCA and its partner institutions will provide clinical care in the center.

Hospital Affiliation

• SCCA, along with its partner institutions – Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children’s – is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest.
• The center will be located on the campus of Northwest Hospital & Medical Center, a full-service, acute-care hospital in north Seattle.

Training

• Physicians and medical staff trained in proton therapy at ProCure’s Training and Development Center (TDC)

Treatment

• Capacity to treat approximately 1,400 patients per year at full capacity

Economic Impact

• 400 temporary jobs
• 100 permanent jobs

For More Information

• www.procure.com/wa

Media Contact

• Sky Opila, PCI
• Email: sopila@pcipr.com
• Phone: 312/558-1770